Sponsor:
Children's Hospital Medical Center, Cincinnati
Code:
NCT05750498
Conditions
Autoimmune Hepatitis
Primary Sclerosing Cholangitis
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
No interventions
Brief summary:
Conditions
Autoimmune Hepatitis
Primary Sclerosing Cholangitis
Study ID
NCT05750498
Start date
Apr 28, 2022
Status verified date
Aug, 2026
Completion date
Jun 30, 2033
Anticipated
Primary completion date
Dec 31, 2032
Anticipated
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Enrollment
800 participants
Anticipated
Arms
Children and adolescents with Autoimmune Liver Disease
Interventions
No interventions
Primary outcome measure
Central contacts
Locations
Stanford University
Recruiting
Palo Alto, California, United States, 94304
Contacts
Principal Investigator:
Leina Alrabadi, MD
Riley Children's Health
Recruiting
Indianapolis, Indiana, United States, 46202
Contacts
Ann Klipsch, RN
aeye@iu.eduPrincipal Investigator:
Kyla Tolliver, MD
St. Louis Children's Hospital
Recruiting
St Louis, Missouri, United States, 63110
Contacts
Principal Investigator:
Sakil S Kulkarni, MD
Cincinnati Children's Hospital Medical Center
Recruiting
Cincinnati, Ohio, United States, 45229
Contacts
Principal Investigator:
Amy E Taylor, MD
Nationwide Children's Hospital
Recruiting
Columbus, Ohio, United States, 43205
Contacts
Principal Investigator:
Alexander Weymann, MD
UPMC Children's Hospital of Pittsburgh
Recruiting
Pittsburgh, Pennsylvania, United States, 15224
Contacts
Principal Investigator:
James E Squires, MD
UT Southwestern Medical Center
Recruiting
Dallas, Texas, United States, 75390
Contacts
Principal Investigator:
Sindhu Pandurangi, MD
Seattle Children's Hospital
Recruiting
Seattle, Washington, United States, 98105
Contacts
Principal Investigator:
Katelyn M Saarela, DO
Sponsor
Children's Hospital Medical Center, Cincinnati
Last update posted
Aug 19, 2026
Last verified
Aug, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2026-08-19.